GlassScriptPhysician profile
Bharat M Desai
NPI 1437111226
$1,389,764.81
in general payments reported to CMS, 2019-2025
15 companies · $398K in 2025
The $398K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75K · 2020: $44K · 2021: $84K · 2022: $149K · 2023: $309K · 2024: $331K · 2025: $398K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $927K · Consulting Fee: $87K · Travel and Lodging: $17K · Food and Beverage: $5,828.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $927,462.67 |
| Consulting Fee | $87,150.00 |
| Travel and Lodging | $17,254.78 |
| Food and Beverage | $5,827.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $1,191,479.72 | 2019-2025 | |
| Treace Medical Concepts, INC. | $139,275.93 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $38,352.30 | 2019-2024 | |
| Gemini Mountain Medical, LLC | $7,688.16 | 2019-2025 | |
| Stryker Corporation | $5,342.23 | 2021-2025 | Prophecy, Inbone, Invision |
| Arthrex, INC. | $4,614.76 | 2019-2025 | Arthrex |
| Smith+Nephew, INC. | $1,671.30 | 2019-2022 | |
| Ziehm-Orthoscan, INC. | $302.12 | 2019 | |
| Heron Therapeutics, INC. | $223.12 | 2021-2025 | Zynrelef |
| Depuy Synthes Sales INC. | $219.70 | 2019-2020 | |
| Paragon 28, INC. | $129.26 | 2022 | |
| Becton, Dickinson and Company | $128.53 | 2022 | |
| Gemini Medical LLC | $124.97 | 2021 | |
| Seaspine Orthopedics Corporation | $118.17 | 2019 | |
| Globus Medical, INC. | $94.54 | 2023 | Ankle Fracture System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bharat Desai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.